Saudi-headquartered healthtech startup DawaDose has announced the successful close of its Pre-Seed funding round, backed by a group of angel investors. With this milestone, the company has begun setting up its headquarters in Saudi Arabia, making the Kingdom the central hub for its development, operations, and regional expansion across the Gulf.
Founded by Rushdi Abdalghani (Co-Founder & CEO) and Osama Almabroum (Co-Founder & Business Development Lead), DawaDose is building the region’s first fully integrated B2C and B2B pharmaceutical ecosystem. Its digital platform connects pharmacies, wholesalers, and consumers through secure, efficient, and accessible tools, in line with Saudi Arabia’s Vision 2030 agenda for digital transformation in healthcare.
“This funding is not just capital; it’s trust — trust in our vision to digitise healthcare access across the Middle East, starting with Saudi Arabia,” said Abdalghani. Almabroum added, “We are building DawaDose as a Saudi company with a global outlook. This is just the first step toward reshaping pharmaceutical e-commerce in the region.”
The new funding will accelerate development of Arabic-first AI-driven healthcare tools, expand partnerships with local pharmacies and distributors, and lay the foundation for DawaDose’s regional expansion strategy.
